660 related articles for article (PubMed ID: 33128625)
1. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
De Basagoiti A; Katsumiti A; Abascal S; Bustinza A; López-Giménez LR; Pascual P; De Miguel M; Campino A
Eur J Pediatr; 2021 Apr; 180(4):1169-1176. PubMed ID: 33128625
[TBL] [Abstract][Full Text] [Related]
2. Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration.
Foushee JA; Fox LM; Gormley LR; Lineberger MS
Am J Health Syst Pharm; 2015 Mar; 72(6):483-6. PubMed ID: 25736944
[TBL] [Abstract][Full Text] [Related]
3. Frequently acquired drugs in neonatal intensive care and their physical compatibility.
Nezvalova-Henriksen K; Holm TH; Nilsson N; Kjønniksen I; Tho I
Acta Paediatr; 2022 Dec; 111(12):2307-2314. PubMed ID: 36017656
[TBL] [Abstract][Full Text] [Related]
4. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
Foushee JA; Meredith P; Fox LM; Wilder AG
Am J Health Syst Pharm; 2020 Jul; 77(14):1144-1148. PubMed ID: 32537625
[TBL] [Abstract][Full Text] [Related]
5. Physical and chemical compatibility of intravenous ciprofloxacin with other drugs.
Jim LK
Ann Pharmacother; 1993 Jun; 27(6):704-7. PubMed ID: 8329786
[TBL] [Abstract][Full Text] [Related]
6. Co-administration of drugs with parenteral nutrition in the neonatal intensive care unit-physical compatibility between three components.
Nilsson N; Storesund I; Tho I; Nezvalova-Henriksen K
Eur J Pediatr; 2022 Jul; 181(7):2685-2693. PubMed ID: 35422115
[TBL] [Abstract][Full Text] [Related]
7. Drug compatibility in neonatal intensive care units: gaps in knowledge and discordances.
Fernández-Peña A; Katsumiti A; De Basagoiti A; Castaño M; Ros G; Sautua S; De Miguel M; Campino A
Eur J Pediatr; 2021 Jul; 180(7):2305-2313. PubMed ID: 33738517
[TBL] [Abstract][Full Text] [Related]
8. Supporting the use of sildenafil infusions in paediatric and neonatal intensive care - A compatibility study.
AlSalman F; Howlett M; Breatnach C; Kelly H; O'Brien F
Eur J Pharm Biopharm; 2020 Jun; 151():153-161. PubMed ID: 32289494
[TBL] [Abstract][Full Text] [Related]
9. Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.
Kondo M; Yoshida N; Yoshida M; Tanaka C; Tagami T; Horikawa K; Sugaya K; Takase H
Am J Health Syst Pharm; 2023 Jan; 80(1):e53-e58. PubMed ID: 36094564
[TBL] [Abstract][Full Text] [Related]
10. Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
Mann HJ; Demmon SL; Boelk DA; Payne CA; Effron MB; Rajagopalan N; Williams MD; Beck GM; Gopalrathnam G
Am J Health Syst Pharm; 2004 Dec; 61(24):2664-71. PubMed ID: 15646701
[TBL] [Abstract][Full Text] [Related]
11. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Lu J; Liu Q; Kupiec TC; Vail H; Lynch LR; Fam DS; Vu NT
Int J Pharm Compd; 2021; 25(1):52-61. PubMed ID: 33503010
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
De Silva DTN; Petrovski M; Strunk T; Mukadam N; Page-Sharp M; Moore BR; Batty KT
Eur J Clin Pharmacol; 2024 Jul; 80(7):1079-1087. PubMed ID: 38546840
[TBL] [Abstract][Full Text] [Related]
13. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Trissel LA; Martinez JF; Gilbert DL
Am J Health Syst Pharm; 1997 Aug; 54(15):1735-41. PubMed ID: 9262747
[TBL] [Abstract][Full Text] [Related]
14. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
Foushee JA; Meredith P; Fox LM; Grace E
Int J Pharm Compd; 2016; 20(4):328-332. PubMed ID: 28333677
[TBL] [Abstract][Full Text] [Related]
15. Physical Compatibility of Alprostadil with Commonly Used IV Solutions and Medications in the Neonatal Intensive Care Unit.
Dice JE
J Pediatr Pharmacol Ther; 2006 Oct; 11(4):233-6. PubMed ID: 23115539
[TBL] [Abstract][Full Text] [Related]
16. [Physical compatibility of furosemide in intravenous mixtures for continuous perfusion].
Pérez Juan E; Maqueda Palau M; Arévalo Rubert M; Ribas Nicolau B; Amorós Cerdá SM
Enferm Intensiva; 2010; 21(3):96-103. PubMed ID: 20413337
[TBL] [Abstract][Full Text] [Related]
17. Y-site Injection Physical Compatibility of Remdesivir with Select Intravenous Drugs Used in Palliative Care and for Treating Coronavirus Disease 2019.
Kondo M; Gempei M; Watanabe K; Yoshida M; Tagui N; Fukao S; Sugaya K; Takase H
J Nippon Med Sch; 2023 Nov; 90(5):381-386. PubMed ID: 37271548
[TBL] [Abstract][Full Text] [Related]
18. Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.
Greenhill K; Hornsby E; Gorman G
Pharmaceuticals (Basel); 2019 May; 12(2):. PubMed ID: 31060247
[TBL] [Abstract][Full Text] [Related]
19. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Singh BN; Dedhiya MG; DiNunzio J; Chan P; Kupiec TC; Trissel LA; Laudano JB
Am J Health Syst Pharm; 2011 Nov; 68(22):2163-9. PubMed ID: 22058102
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of a compatibility chart for intravenous drug therapy in neonatal and pediatric intensive care units].
Höpner JH; Schulte A; Thiessen J; Knuf M; Huth RG
Klin Padiatr; 2007; 219(1):37-43. PubMed ID: 17205430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
